Category Archives: "Partners"

Nine CMSC 2016 Annual Meeting exclusive interviews you can’t miss
This year, Multiple Sclerosis News Today offered expanded coverage of the 2016 Annual Meeting of the Consortium of Multiple Sclerosis [...]
CMSC 2016 Annual Meeting – Fingolimod (Gilenya) offers consistent health benefits in RRMS patients
Researchers at the Swedish Neuroscience Institute in Washington and Novartis Pharma revealed that Gilenya (fingolimod) induced a [...]
CMSC 2016 Annual Meeting – multiple sclerosis patients, physical therapists have distinct decision-making processes
Understanding and combining decision-making processes of both patients with multiple sclerosis (MS) and physical therapists to improve [...]
CMSC 2016 Annual Meeting – multiple sclerosis duration and disability level variously impacts arm function
Most research in multiple sclerosis (MS) has focused on the impact of the disease on the lower extremities. To balance this, researchers [...]
CMSC 2016 Annual Meeting – multiple sclerosis and yoga: author and instructor says ancient discipline can help patients
Mindy Eisenberg is the author of the book “Adaptive Yoga Moves Any Body” and Multiple Sclerosis News Today had the chance to hear [...]
CMSC 2016 Annual Meeting – Ocrevus (Ocrelizumab) in PPMS prevented disability progression
Data recently presented at the Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting showed that Roche/Genentech’s [...]
CMSC 2016 Annual Meeting – medical affairs vice president at EMD Serono discusses multiple sclerosis drug rebif, Multiple Sclerosis LifeLines
EMD Serono, the U.S. and Canadian subsidiary and biopharmaceutical business of Merck KGaA, focuses exclusively on specialty care. With [...]
CMSC congratulates Kessler Foundation for this prestigious recognition
We are extremely pleased to tell you that Kessler Foundation has been ranked #5 on a list of the “50 Best Workplaces for Recent College [...]
Dr. Ellen Mowry, in Interview, talks of clinical studies for Vitamin D & multiple sclerosis
With an interest multiple sclerosis (MS) before even starting college, Dr. Ellen Mowry has spent her entire research career investigating [...]
High glutamate levels in brain seen to drive multiple sclerosis progression
Patients with multiple sclerosis (MS) have increased levels of the neurotransmitter glutamate in their brains, lowering the levels of [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last